Cytokine-induced killer (CIK) cells, which are non-major histocompatibility complex (MHC)-restricted CD3+CD56+T cells, take advantage of the body’s natural ability to eliminate tumor cells by stimulating and restoring the immune system to recognize and kill tumor cells. This evidence concerns the gene NCAM1 and neoplasm.